Common variants in the GLP-1 receptor are associated with glycaemic response to GLP-1 receptor agonists in observational and large RCT data: an IMI-DIRECT study

被引：0

作者：

Dawed, A. Y. ^{[1
]}

Mari, A. ^{[2
]}

McDonald, T. J. ^{[3
,4
]}

Robertson, N. R. ^{[5
]}

Mahajan, A. ^{[6
]}

Walker, M. ^{[7
]}

Gough, S. ^{[8
]}

Zhou, K. ^{[1
]}

Forgie, I. ^{[1
]}

Ruetten, H. ^{[9
]}

Pavo, I. ^{[10
]}

Pillai, S. G. ^{[10
]}

Jones, A. G. ^{[3
,4
]}

Pearson, E. R. ^{[1
]}

机构：

[1] Univ Dundee, Mol & Clin Med, Dundee, Scotland

[2] CNR, Inst Neurosci, Padua, Italy

[3] Univ Exeter, NIHR Exeter Clin Res Facil, Exeter, Devon, England

[4] Royal Devon & Exeter Hosp, Exeter, Devon, England

[5] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Clin Med, Oxford, England

[6] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England

[7] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

[8] NIHR Oxford Biomed Res Ctr, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England

[9] Sanofi Aventis Deutsch GmbH, TMED, Frankfurt, Germany

[10] Eli Lilly Res Labs, Indianapolis, IN USA

来源：

DIABETOLOGIA | 2018年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S21 / S21

页数：1

共 50 条

[1] GLP-1 RECEPTOR VARIANTS MARKEDLY DIFFERENTIATE GLYCAEMIC RESPONSE TO GLP-1 RECEPTOR AGONISTS: A DIRECT STUDY
Dawed, A. Y.
Mari, A.
McDonald, T. J.
Hong, M. -G
Sharma, S.
Robertson, N. R.
Mahajan, A.
Walker, M.
Gough, S.
Zhou, K.
Forgie, I
Ruetten, H.
Jones, A. G.
Pearson, E. R.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 14
[2] GLP-1 receptor variants markedly differentiate glycaemic response to GLP-1 receptor agonists: a DIRECT study
Dawed, A. Y.
Mari, A.
McDonald, T. J.
Hong, M. G.
Sharma, S.
Robertson, N. R.
Mahajan, A.
Walker, M.
Gough, S.
Zhou, K.
Forgie, I.
Ruetten, H.
Jones, A. G.
Pearson, E. R.
DIABETOLOGIA, 2017, 60 : S393 - S393
[3] GLP-1 receptor agonists in NAFLD
Petit, J. -M.
Verges, B.
DIABETES & METABOLISM, 2017, 43 : 2S28 - 2S33
[4] GLP-1 receptor agonists and suicidality
Ueda, Peter
Pasternak, Bjorn
BMJ-BRITISH MEDICAL JOURNAL, 2025, 388
[5] Emerging GLP-1 receptor agonists
Lund, Asger
Knop, Filip K.
Vilsboll, Tina
EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 607 - 618
[6] GLP-1 receptor agonists today
Marre, Michel
Penfornis, Alfred
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (03) : 317 - 327
[7] Positioning on GLP-1 receptor agonists
Gimenez, Sergio
Piskorz, Daniel
Martinez Demaria, Diego
Nanfara, Silvia
Lorenzatti, Alberto
Zapata, Gerardo
Aguinaga Arrascue, Luis
Perna, Eduardo
REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 : 4 - 10
[8] The Future of the GLP-1 Receptor Agonists
Hirsch, Irl B.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (15): : 1457 - 1458
[9] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
Reactions Weekly, 2025, 2044 (1) : 3 - 3
[10] GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
Singh, Anmol
Sohal, Aalam
Batta, Akash
WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (48)

← 1 2 3 4 5 →